Endogenous opiates: 1981.
This paper is the fourth of an annual series reviewing the research concerning the endogenous opiate peptides. This installment covers only work published during 1981 and attempts to provide a comprehensive, but not exhaustive, survey of the area. Previous papers in the series have dealt with research done before 1981. Topics concerning endogenous opiates reviewed here include a delineation of their receptors, their distribution, their precursors and degradation, behavioral effects resulting from their administration, their possible involvement in physiological responses, and their interactions with other peptides and hormones. Due to the burgeoning literature in this field, the comprehensive nature of this review in the future will be limited to considerations of behavioral phenomena related to the endogenous opiates.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004361:Drug Tolerance; D010450:Endopeptidases / Q000378:metabolism; D004723:Endorphins / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007858:Learning / Q000502:physiology; D015260:Neprilysin; D010146:Pain / Q000503:physiopathology; D010455:Peptides / Q000502:physiology; D011957:Receptors, Opioid / Q000378:metabolism / Q000502:physiology; D013045:Species Specificity; D013312:Stress, Physiological / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000503:physiopathology
D004723:Endorphins; D010455:Peptides; D011957:Receptors, Opioid; D010450:Endopeptidases; D015260:Neprilysin